DiHydro-GP Interactions
There are 656 drugs known to interact with DiHydro-GP (dihydrocodeine / guaifenesin / pseudoephedrine), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 132 are major, 518 are moderate, and 6 are minor.
- View all 656 medications that may interact with DiHydro-GP
- View DiHydro-GP alcohol/food interactions (2)
- View DiHydro-GP disease interactions (22)
Most frequently checked interactions
View interaction reports for DiHydro-GP (dihydrocodeine / guaifenesin / pseudoephedrine) and the medicines listed below.
- acetaminophen
- acetaminophen
- acetazolamide
- acetazolamide
- Acetylsalicylic Acid (aspirin)
- Acetylsalicylic Acid (aspirin)
- acyclovir
- acyclovir
- Adenoscan (adenosine)
- Adenoscan (adenosine)
- Albuminar-25 (albumin human)
- Albuminar-25 (albumin human)
- albuterol
- albuterol
- alprazolam
- alprazolam
- aluminum hydroxide
- aluminum hydroxide
- atorvastatin
- atorvastatin
- clopidogrel
- clopidogrel
- furosemide
- furosemide
- insulin
- insulin
- ranitidine
- ranitidine
- warfarin
- warfarin
DiHydro-GP alcohol/food interactions
There are 2 alcohol/food interactions with DiHydro-GP (dihydrocodeine / guaifenesin / pseudoephedrine).
DiHydro-GP disease interactions
There are 22 disease interactions with DiHydro-GP (dihydrocodeine / guaifenesin / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about DiHydro-GP (dihydrocodeine / guaifenesin / pseudoephedrine)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.